Biolab offers Hemoglobinopathies Screening Panel for early diagnosis of blood disorders

In an effort to diversify its assortment of medical tests to cover the most prevalent conditions, Biolab, the exclusive Biomnis dealer in the Kingdom, offers Hemoglobinopathies Screening Panel tests that help diagnose hereditary blood disorders, which result in diminished production of hemoglobin.

Biolab designed this test package due to the increasing prevalence of blood disorders in Jordan within various social segments and age groups, a phenomenon attributed primarily to the culture of consanguinity, which currently constitutes more than a third of Jordanian marriages, and which dramatically increases the odds of genetic disorders like hemoglobinopathies.

The Hemoglobinopathies Screening Panel conforms to the globally adopted strategy of isolating hemoglobin variants through hemoglobin electrophoresis, which is conducted within the lab. This is followed by a number of molecular diagnostic tests capable of identifying various genetic blood disorders, such as alpha thalassemia, beta thalassemia, and sickle cell anemia, allowing carriers and patients to accurately diagnose and treat these conditions at the earliest possible stage, thereby improving health standards within the community.

Biolab is a pioneer in applying advances in medicine and science to laboratory testing, providing a broad range of medical diagnostic services to individuals, physicians, hospitals and other laboratories, in addition to offering a wide array of medical, scientific and consultancy services in the fields of health and diagnostics. Leveraging on cutting-edge technology,high caliber staff and an extensive insurance and bank affiliate network, Biolab offers its patients an unparalleled premium experience, prioritizing reliability, accountability and convenience.